Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin

Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Khandakar, Ullah, Saad, Tahir, Hassan, Alkilani, Waseem Zaid, Naeem, Muhammad, Vinod, Nagadarshini Ramagiri, Massoud, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027907/
https://www.ncbi.nlm.nih.gov/pubmed/27689100
http://dx.doi.org/10.1177/2324709616665408
Descripción
Sumario:Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibiotic use, and immunosuppression. In this article, we report a case of daptomycin-resistant enterococcal native infective endocarditis treated with off-label use of quinupristin-dalfopristin.

Ejemplares similares